+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Impetigo Drug"

Impetigo Drugs - Global Strategic Business Report - Product Thumbnail Image

Impetigo Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 193 Pages
  • Global
From
From
From
Impetigo - Epidemiology Forecast to 2032 - Product Thumbnail Image

Impetigo - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Impetigo - Pipeline Insight, 2024 - Product Thumbnail Image

Impetigo - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Impetigo is a contagious skin infection caused by bacteria. It is most common in children, but can affect people of any age. Treatment for impetigo typically involves antibiotics, either topical or oral. The Impetigo Drug market is a subset of the Infectious Diseases Drugs market, which includes drugs used to treat a wide range of bacterial, viral, and fungal infections. The Impetigo Drug market is composed of a variety of antibiotics, including penicillin, cephalosporins, macrolides, and sulfonamides. These drugs are used to treat the infection and reduce the risk of complications. In addition, some drugs are used to reduce the risk of recurrence. The Impetigo Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, Novartis, and Johnson & Johnson. Show Less Read more